Atlas Trials

BE Study of the Combinations of Gemigliptin 50mg and Metformin HCl Extended Release 1000mg in Comparison to Each Component Administered Alone

Clinical trial NCT01662674 · COMPLETED

Trial details

NCT number
NCT01662674
Sponsor
LG Life Sciences
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2012-10-01
Primary completion
2012-11-01
Enrollment
27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.